Your position:m.limatoxi.com>>EN>>EN>>Formulation>>Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia>> article
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
Editor:xuezhe Clicks:0Date:2023-2-10 15:17:32
Keyword:Ribo Biologics
Healthoo Information:
Ribo Biologics announced that the worlds first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • D-Ribose reference price
  • New Tuoyang Bios first production line of isotretinoin C sodium D- rib...
  • D-Ribose reference price
  • D-Ribose reference price
  • Riboflavin sodium phosphate reference price
  • D-Ribose reference price
  • D-Ribose reference price
  • Guangji to resume Vitamin B2 production
  • D-Ribose reference price
  • Guangji and Hegno increased Riboflavin prices
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map